NCT03091348View on ClinicalTrials.gov

Subcutaneous vs. Intramuscular Testosterone

PHASE4CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 29, 2017

Primary Completion Date

November 21, 2017

Study Completion Date

January 2, 2018

Conditions
Testosterone DeficiencyHypogonadism, Male
Interventions
DRUG

Testosterone

Testosterone cypionate injection

Trial Locations (1)

02467

Men's Health Boston, Chestnut Hill

All Listed Sponsors
lead

Men's Health Boston

OTHER

NCT03091348 - Subcutaneous vs. Intramuscular Testosterone | Biotech Hunter | Biotech Hunter